These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 32801705)

  • 21. Fatty acid synthase is a primary target of MiR-15a and MiR-16-1 in breast cancer.
    Wang J; Zhang X; Shi J; Cao P; Wan M; Zhang Q; Wang Y; Kridel SJ; Liu W; Xu J; Zhang Q; Sui G
    Oncotarget; 2016 Nov; 7(48):78566-78576. PubMed ID: 27713175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted small interfering RNA-immunoliposomes as a promising therapeutic agent against highly pathogenic Avian Influenza A (H5N1) virus infection.
    Khantasup K; Kopermsub P; Chaichoun K; Dharakul T
    Antimicrob Agents Chemother; 2014 May; 58(5):2816-24. PubMed ID: 24614365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of breast cancer cell growth and invasiveness by dual silencing of HER-2 and VEGF.
    Tai W; Qin B; Cheng K
    Mol Pharm; 2010 Apr; 7(2):543-56. PubMed ID: 20047302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy.
    Eloy JO; Petrilli R; Chesca DL; Saggioro FP; Lee RJ; Marchetti JM
    Eur J Pharm Biopharm; 2017 Jun; 115():159-167. PubMed ID: 28257810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EGFR-specific PEGylated immunoliposomes for active siRNA delivery in hepatocellular carcinoma.
    Gao J; Yu Y; Zhang Y; Song J; Chen H; Li W; Qian W; Deng L; Kou G; Chen J; Guo Y
    Biomaterials; 2012 Jan; 33(1):270-82. PubMed ID: 21963149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The mTOR inhibitor rapamycin synergizes with a fatty acid synthase inhibitor to induce cytotoxicity in ER/HER2-positive breast cancer cells.
    Yan C; Wei H; Minjuan Z; Yan X; Jingyue Y; Wenchao L; Sheng H
    PLoS One; 2014; 9(5):e97697. PubMed ID: 24866893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Docosahexaenoic acid reduces sterol regulatory element binding protein-1 and fatty acid synthase expression and inhibits cell proliferation by inhibiting pAkt signaling in a human breast cancer MCF-7 cell line.
    Huang LH; Chung HY; Su HM
    BMC Cancer; 2017 Dec; 17(1):890. PubMed ID: 29282029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DC-Chol/DOPE cationic liposomes: a comparative study of the influence factors on plasmid pDNA and siRNA gene delivery.
    Zhang Y; Li H; Sun J; Gao J; Liu W; Li B; Guo Y; Chen J
    Int J Pharm; 2010 May; 390(2):198-207. PubMed ID: 20116418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer.
    Migita T; Ruiz S; Fornari A; Fiorentino M; Priolo C; Zadra G; Inazuka F; Grisanzio C; Palescandolo E; Shin E; Fiore C; Xie W; Kung AL; Febbo PG; Subramanian A; Mucci L; Ma J; Signoretti S; Stampfer M; Hahn WC; Finn S; Loda M
    J Natl Cancer Inst; 2009 Apr; 101(7):519-32. PubMed ID: 19318631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcriptomic and cellular analyses of CRISPR/Cas9-mediated edition of FASN show inhibition of aggressive characteristics in breast cancer cells.
    Gonzalez-Salinas F; Rojo R; Martinez-Amador C; Herrera-Gamboa J; Trevino V
    Biochem Biophys Res Commun; 2020 Aug; 529(2):321-327. PubMed ID: 32703430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The promotion of siRNA delivery to breast cancer overexpressing epidermal growth factor receptor through anti-EGFR antibody conjugation by immunoliposomes.
    Gao J; Liu W; Xia Y; Li W; Sun J; Chen H; Li B; Zhang D; Qian W; Meng Y; Deng L; Wang H; Chen J; Guo Y
    Biomaterials; 2011 May; 32(13):3459-70. PubMed ID: 21296406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enzyme-sensitive nanoparticles, smart TAT and cetuximab conjugated immunoliposomes to overcome multidrug resistance in breast cancer cells.
    Safaei M; Khosravian P; Kazemi Sheykhshabani S; Mardani G; Elahian F; Mirzaei SA
    Toxicol Appl Pharmacol; 2022 Apr; 441():115989. PubMed ID: 35314202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 'Nano-in-nano' hybrid liposomes increase target specificity and gene silencing efficiency in breast cancer induced SCID mice.
    Bhavsar D; Subramanian K; Sethuraman S; Krishnan UM
    Eur J Pharm Biopharm; 2017 Oct; 119():96-106. PubMed ID: 28600223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Doxorubicin-loaded Fab' fragments of anti-disialoganglioside immunoliposomes selectively inhibit the growth and dissemination of human neuroblastoma in nude mice.
    Pastorino F; Brignole C; Marimpietri D; Sapra P; Moase EH; Allen TM; Ponzoni M
    Cancer Res; 2003 Jan; 63(1):86-92. PubMed ID: 12517782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunoliposomes bearing polyethyleneglycol-coupled Fab' fragment show prolonged circulation time and high extravasation into targeted solid tumors in vivo.
    Maruyama K; Takahashi N; Tagawa T; Nagaike K; Iwatsuru M
    FEBS Lett; 1997 Aug; 413(1):177-80. PubMed ID: 9287139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapamycin-loaded Immunoliposomes Functionalized with Trastuzumab: A Strategy to Enhance Cytotoxicity to HER2-positive Breast Cancer Cells.
    Eloy JO; Petrilli R; Brueggemeier RW; Marchetti JM; Lee RJ
    Anticancer Agents Med Chem; 2017; 17(1):48-56. PubMed ID: 27225450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leucine deprivation inhibits proliferation and induces apoptosis of human breast cancer cells via fatty acid synthase.
    Xiao F; Wang C; Yin H; Yu J; Chen S; Fang J; Guo F
    Oncotarget; 2016 Sep; 7(39):63679-63689. PubMed ID: 27579768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of Fatty Acid Synthase (FASN) synergistically enhances the efficacy of 5-fluorouracil in breast carcinoma cells.
    Vazquez-Martin A; Ropero S; Brunet J; Colomer R; Menendez JA
    Oncol Rep; 2007 Oct; 18(4):973-80. PubMed ID: 17786362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation of pH-sensitive, long-circulating and EGFR-targeted immunoliposomes.
    Kim MJ; Lee HJ; Lee IA; Kim IY; Lim SK; Cho HA; Kim JS
    Arch Pharm Res; 2008 Apr; 31(4):539-46. PubMed ID: 18449514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel positive feedback loop involving FASN/p-ERK1/2/5-LOX/LTB4/FASN sustains high growth of breast cancer cells.
    Hu N; Li Y; Zhao Y; Wang Q; You JC; Zhang XD; Ye LH
    Acta Pharmacol Sin; 2011 Jul; 32(7):921-9. PubMed ID: 21643005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.